C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2011
12/29/2011	US20110318352 Compositions and methods for the treatment of viral infections
12/29/2011	US20110318342 Methods of using il-1 antagonists to treat autoinflammatory disease
12/29/2011	US20110318301 Il-17a/f heterologous polypeptides and therapeutic uses thereof
12/29/2011	US20110318275 Multifunctional contrast agent using biocompatible polymer and preparation method
12/29/2011	US20110318274 Variant of mite allergen and uses thereof
12/29/2011	US20110318264 Methods and compositions for diagnosis and treatment of cancer
12/29/2011	CA2840431A1 Compositions and methods for treatment of thrombosis and for prolonging survival of stored platelets
12/29/2011	CA2804945A1 Reversed phase hplc purification of a glp-1 analogue
12/29/2011	CA2803859A1 Immunosuppression modulating compounds
12/29/2011	CA2803391A1 Colon and pancreas cancer specific antigens and antibodies
12/29/2011	CA2803343A1 Aspergillus aculeatus derived polypeptides having c4-dicarboxylic acid transporter activity and polynucleotides encoding same
12/29/2011	CA2803164A1 Amide-based insulin prodrugs
12/29/2011	CA2803102A1 Methyltransferase nucleic acids and polypeptides
12/29/2011	CA2803058A1 Homodimeric protein constructs
12/29/2011	CA2802971A1 New medium, devices and methods
12/29/2011	CA2802964A1 Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
12/29/2011	CA2802919A1 Genetic markers associated with intellectual disability
12/29/2011	CA2802897A1 Glucagon analogues
12/29/2011	CA2802889A1 Glucagon analogues
12/29/2011	CA2802510A1 Insulin derivatives containing additional disulfide bonds
12/29/2011	CA2800841A1 Anticancer fusion protein
12/29/2011	CA2800261A1 Treatment of vascular complications of diabetes
12/29/2011	CA2798100A1 Novel jnk inhibitor molecules
12/29/2011	CA2796894A1 Amide based glucagon superfamily peptide prodrugs
12/29/2011	CA2796879A1 Dipeptide linked medicinal agents
12/28/2011	EP2400038A1 Methods and nucleic acid constructs for screening for compounds capable of modulating VEGF expression
12/28/2011	EP2400021A2 ErbB3 based methods and compositions for treating neoplasms
12/28/2011	EP2400019A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400018A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400017A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400016A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400015A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400014A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400013A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400012A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400011A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400010A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400009A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400008A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400007A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400006A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400005A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400004A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400003A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400002A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400001A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400000A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399999A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399998A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399997A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399996A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399995A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399993A1 Hypo-immunogenic streptavidin and use thereof
12/28/2011	EP2399948A1 Cationic poly(amino acids) and uses thereof
12/28/2011	EP2399939A2 Target activated cell/tissue translocation peptide for impermeable compound strategy, and uses thereof
12/28/2011	EP2399932A1 Compositions and methods for modulating immune responses
12/28/2011	EP2399931A1 New octapeptide compounds and their therapeutic use
12/28/2011	EP2399930A1 N-terminally monopegylated polypeptides and process for their preparation
12/28/2011	EP2399929A2 Polypeptide having function for delaying anthesis or suppressing growth, polynucleotide encoding the same, and use thereof
12/28/2011	EP2399928A1 Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
12/28/2011	EP2399925A1 Method for fluorescently labeling protein
12/28/2011	EP2399606A1 A method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
12/28/2011	EP2399602A1 HIV-1 Clade A consensus sequences, antigens, and transgenes
12/28/2011	EP2399599A2 Mucin hypersecretion inhibitors and methods of use
12/28/2011	EP2399598A1 Blockade of CCL18 signaling via CCR6 as a therapeutic option in fibrotic diseases and cancer
12/28/2011	EP2398905A1 Novel kinase-start gene conferring resistance to plant disease and transgenic plants comprising it
12/28/2011	EP2398904A1 Means for purifying a coagulation protein, and methods for implementing same
12/28/2011	EP2398902A1 Methods and compositions for diagnosis and treatment of cancer
12/28/2011	EP2398896A2 Cell culture media containing combinations of proteins
12/28/2011	EP2398892A1 Live attenuated vaccines
12/28/2011	EP2398826A2 Improved anti-serum albumin binding variants
12/28/2011	EP2398824A1 Means and methods for manufacturing highly pure neurotoxin
12/28/2011	EP2398822A1 Modification of factor viii
12/28/2011	EP2398821A1 Inactivated dengue virus vaccine with aluminium-free adjuvant
12/28/2011	EP2398818A1 Means for purifying a protein of blood plasma and methods for implementing same
12/28/2011	EP2398494A2 Proproteins and methods of use thereof
12/28/2011	EP2398490A2 Modifications of cupredoxin derived peptides and methods of use thereof
12/28/2011	EP2398485A1 Analogues of neuropeptide y having at least one synthetic amino acid substitution
12/28/2011	EP2398483A1 Oxyntomodulin analogs
12/28/2011	EP2385071A9 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/28/2011	EP2170941B1 Preprocalcitonin antigen t epitopes
12/28/2011	EP2132224B1 Cyclic receptor-associated protein (rap) peptides
12/28/2011	EP1966240B3 Lactoferrin peptides useful as cell-penetrating peptides
12/28/2011	EP1940874B1 Botulinum neurotoxin a protein receptor and uses thereof
12/28/2011	EP1802654B1 Method for the isolation of haptoglobin
12/28/2011	EP1704164B1 Interleukin-11 fusion proteins
12/28/2011	EP1644037B1 Functional influenza virus-like particles (vlps)
12/28/2011	EP1572080B1 Fgf variants and methods for use thereof
12/28/2011	EP1546336B1 Polynucleotides and polypeptides in plants
12/28/2011	EP1412496B1 Reversed mammalian protein-protein interaction trap
12/28/2011	EP1234033B1 Methods for targeting cells that express fibroblast growth factor receptor-3 or-2
12/28/2011	CN1960699B 角蛋白结合多肽 Keratin-binding polypeptide
12/28/2011	CN1774259B 治疗系统性红斑狼疮的肽的胃肠道外制剂 Parenteral preparations for treatment of systemic lupus erythematosus peptides
12/28/2011	CN1671737B 以羊毛硫抗生素途径输出并修饰(多)肽 In lantibiotic export pathway and modified (poly) peptide
12/28/2011	CN102300992A 为增强转基因植物的干旱抗性和提高其产量而工程化nf-yb转录因子 To enhance the drought tolerance of transgenic plants and enhance their yield and engineered transcription factor nf-yb
12/28/2011	CN102300987A 膜型-1基质金属蛋白抑制剂及其用途 -1 Membrane type matrix metalloproteinase inhibitors and their use
12/28/2011	CN102300877A 与糖尿病肾病相关的尿及血清的生物标记 And diabetic nephropathy urine and serum biomarkers
12/28/2011	CN102300875A 肾病相关的生物标记 Nephropathy biomarkers
12/28/2011	CN102300874A Tmem154多肽和多核苷酸及其作为产生药物和生物制品的药物靶标的用途 Tmem154 polypeptides and polynucleotides and produce drugs and biological products as potential targets for drug use
12/28/2011	CN102300872A 猿腺病毒核酸和氨基酸序列，包含其的载体及其用途 Simian adenovirus nucleic acid and amino acid sequences, including its carrier and its use

1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 2916